LONDON (Reuters) -Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the ...
The financial results show top-line sales growth in the first nine months of the year of 12% to DKK 230 billion ($35.4 ...
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecasts again on Wednesday, in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback